ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/11/2026
Back to search
Official data from USPTO
CARDIOCEQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/13/2026
Trademark type
Word
Nice classes
5
Filing date
06/02/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
06/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Lantheus Biosciences Ltd.
Life Molecular Imaging Limited
Life Molecular Imaging Ltd.
Representatives
Heather E Balmat Balmat Law, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; diagnostic materials in the nature of reagents for medical purposes; diagnostic agents for medical use
Publications
History of USPTO decisions and trademark events.
34 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/09/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/21/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2023
FIMP
FINAL DISPOSITION PROCESSED
06/27/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/21/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/16/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/15/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/15/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/28/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/14/2022
GNFR
FINAL REFUSAL E-MAILED
10/14/2022
CNFR
FINAL REFUSAL WRITTEN
10/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2022
RFNT
REFUSAL PROCESSED BY IB
04/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/23/2022
RFRR
REFUSAL PROCESSED BY MPU
03/23/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/23/2022
CNRT
NON-FINAL ACTION WRITTEN
02/22/2022
DOCK
ASSIGNED TO EXAMINER
02/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/09/2021
Continuous trademark protection
Get notified about every new filing that threatens CARDIOCEQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.